Disc Medicine, Inc.
IRON- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001816736
In the last 90 days, Disc Medicine, Inc. insiders filed 0 open-market purchases and 9 sales; 216 institutions reported holding it in 13F filings for Q2 2026, worth $3.13B in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Disc Medicine, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 51 | 44 | −7 |
| Shares | 25.9M | 26.7M | +829.3K (+3.2%) |
| Value | $43.8M | $43.9M | +$44.0K (+0.1%) |
New holders (6)
Institutions that held Disc Medicine, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| 5AM Venture Management, LLC | 524,500 | $860.0K | 0.16% |
| Nantahala Capital Management, LLC | 257,672 | $423.0K | 0.04% |
| ExodusPoint Capital Management, LP | 51,779 | $85.0K | 0.00% |
| Wolverine Trading, LLC | 16,030 | $24.0K | 0.00% |
| Group One Trading, L.P. | 6,455 | $11.0K | 0.00% |
| Royal Bank of Canada | 131 | $0 | 0.00% |
Sold out (13)
Institutions that held Disc Medicine, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Ikarian Capital, LLC | 443,096 | $749.0K |
| Bank of Montreal | 150,393 | $276.0K |
| Marquette Asset Management, LLC | 87,648 | $148.0K |
| Crestline Management, LP | 61,701 | $104.0K |
| Boothbay Fund Management, LLC | 42,297 | $71.0K |
| Prelude Capital Management, LLC | 31,099 | $53.0K |
| Susquehanna International Group, LLP | 29,002 | $49.0K |
| Diametric Capital, LP | 27,563 | $47.0K |
| Virtu Financial LLC | 20,530 | $35.0K |
| Penserra Capital Management LLC | 11,369 | $19.0K |
| New York State Common Retirement Fund | 201 | $0 |
| Credit Suisse AG | 12 | $0 |
| Capital Advisors, Ltd. LLC | 68 | $0 |